Healthcare Triangle, Inc.
General ticker "HCTI" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $19.0K (TTM average)
Healthcare Triangle, Inc. does not follow the US Stock Market performance with the rate: -18.9%.
Estimated limits based on current volatility of 0.7%: low 0.41$, high 0.42$
Factors to consider:
- Total employees count: 43 (+30.3%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Cybersecurity threats, Strategic risks and growth management, Regulatory and compliance, Customer concentration
- Current price 98.3% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [23.05$, 111.45$]
- 2026-12-31 to 2027-12-31 estimated range: [9.83$, 46.16$]
Financial Metrics affecting the HCTI estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Negative: Interest expense per share per price, % of 14.59 > 10.35
- Negative: -0.33 < Industry inventory ratio change (median), % of -0.11
- Negative: negative Industry operating income (median)
- Negative: Investing cash flow per share per price, % of -45.05 <= -40.59
Short-term HCTI quotes
Long-term HCTI plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $13.89MM |
| Operating Expenses | $23.68MM |
| Operating Income | $-9.79MM |
| Non-Operating Income | $0.31MM |
| Interest Expense | $0.57MM |
| R&D Expense | $0.54MM |
| Income(Loss) | $-9.48MM |
| Net Income(Loss)* | $-9.48MM |
| Stockholders Equity | $9.98MM |
| Assets | $22.74MM |
| Operating Cash Flow | $-16.52MM |
| Capital expenditure | $0.01MM |
| Investing Cash Flow | $-1.75MM |
| Financing Cash Flow | $25.88MM |
| Earnings Per Share** | $-153.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.